Since CXCR4 was reported to activate the EMT program in colorectal cancer [7,14,15,16], and chemotherapy to induce chemoresistance through the EMT program [5], EMT transition was evaluated as a possible Pep R mechanism of action. Here, CXCR4 is linked to colorectal cancer.